Advertisement
Screener

EMERGENT BIOSOLUTIONS INC. (EBS) Material Contracts, 2011

EMERGENT BIOSOLUTIONS INC. Material Contracts

Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.

  • 2011-12-22: Form 8-K; Exhibit 10.1; Description Emergent BioSolutions Inc. Amended and Restated Senior Management Severance Plan.
  • 2011-11-14: Form 8-K; Exhibit 10.1; Description Emergent BioSolutions Inc. Senior Management Severance Plan.
  • 2011-11-04: Form 10-Q; Exhibit 10.6; Description Notice of Award Letter, dated September 30, 2011, from the Centers for Disease Control and Prevention to Emergent BioDefense Operations Lansing LLC awarding Solicitation 2011-N-13414 for Acquiring Doses of Anthrax Vaccine Absorbed (AVA).
  • 2011-11-04: Form 10-Q; Exhibit 10.5; Description Modification No. 12 to Contract No. HHS0100200700037C, dated August 24, 2011, between Emergent BioDefense Operations Lansing LLC, formerly known as Emergent BioDefense Operations Lansing Inc., and the Department of Health and Human Services.
FiledFormExhibitDescription
2011-12-228-K10.1Emergent BioSolutions Inc. Amended and Restated Senior Management Severance Plan
2011-11-148-K10.1Emergent BioSolutions Inc. Senior Management Severance Plan
2011-11-0410-Q10.6Notice of Award Letter, dated September 30, 2011, from the Centers for Disease Control and Prevention to Emergent BioDefense Operations Lansing LLC awarding Solicitation 2011-N-13414 for Acquiring Doses of Anthrax Vaccine Absorbed (AVA)
2011-11-0410-Q10.5Modification No. 12 to Contract No. HHS0100200700037C, dated August 24, 2011, between Emergent BioDefense Operations Lansing LLC, formerly known as Emergent BioDefense Operations Lansing Inc., and the Department of Health and Human Services
2011-11-0410-Q10.4Modification No. 14 to Contract No. 200-2009-30162, dated September 29, 2011, between Emergent BioDefense Operations Lansing LLC, formerly known as Emergent BioDefense Operations Lansing Inc., and the Centers for Disease Control and Prevention
2011-11-0410-Q10.3Loan and Security Agreement, dated August 3, 2011, among Emergent Manufacturing Operations Baltimore LLC, Emergent BioSolutions Inc. and PNC Equipment Finance, LLC
2011-11-0410-Q10.2Promissory Note, dated July 28, 2011, from Emergent BioSolutions Inc. to PNC Bank, National Association
2011-11-0410-Q10.1Construction Loan Agreement, dated July 28, 2011, among Emergent BioSolutions Inc., Emergent Manufacturing Operations Baltimore LLC and PNC Bank, National Association
2011-08-0510-Q10.9Deed of Surrender, dated May 17, 2011, between Emergent Product Development UK Ltd. and Segro (Winnersh) Limited
2011-08-0510-Q10.8Deed of Surrender, dated May 17, 2011, between Segro (Winnersh) Limited, Emergent Product Development UK Ltd. and Emergent BioSolutions Inc.
2011-08-0510-Q10.7Deed of Variation, dated May 17, 2011, between Emergent Product Development UK Ltd. and Segro (Winnersh) Limited
2011-08-0510-Q10.6Agreement for Surrender, dated May 17, 2011, between Emergent Product Development UK Ltd. and Segro (Winnersh) Limited
2011-08-0510-Q10.5Modification No. 9 to Contract No. HHSO100200700037C, dated June 1, 2011, between Emergent BioDefense Operations Lansing LLC, formerly known as Emergent BioDefense Operations Lansing Inc., and the Department of Health and Human Services
2011-08-0510-Q10.4Consulting Services Agreement, effective April 1, 2011, between the Registrant and The Hauer Group
2011-08-0510-Q10.3Amended and Restated License and Commercialization Agreement, dated December 22, 2009, between TenX BioPharma, Inc. and Genmab A/S
2011-08-0510-Q10.2Amendment No .3 to Collaboration and License Agreement, dated May 26, 2011, between Emergent Product Development Seattle, LLC and Pfizer Inc.
2011-08-0510-Q10.1Modification No. 12 to Contract No. 200-2009-30162, dated May 2, 2011, between Emergent BioDefense Operations Lansing LLC, formerly known as Emergent BioDefense Operations Lansing Inc., and the Centers for Disease Control and Prevention
2011-05-0610-Q10.1Letter Agreement, dated February 17, 2011, between the Registrant and East West Resources Corporation (Incorporated by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K filed with the SEC on February 23, 2011 (File No. 001-33137))
2011-03-1110-K10.50Modification No. 2 of Contract No. HHSO100201000034C, dated December 30, 2010, between Emergent BioDefense Operations Lansing LLC, formerly known as Emergent BioDefense Operations Lansing Inc., and Biomedical Advanced Research and Development Authority of the U.S. Department of Health and Human Services
2011-03-1110-K10.49Supply Agreement, dated January 1, 2011, between Emergent BioDefense Operations Lansing LLC and Hollister-Stier Laboratories LLC
2011-02-238-K10.1Letter agreement between Emergent BioSolutions Inc. and East West Resources Corporation, dated February 17, 2011

Similar stocks

Stock NameCountryMarket CapPE Ratio
ENANTA PHARMACEUTICALS INC (ENTA)United States$0.349B-6.72
Larimar Therapeutics, Inc. (LRMR)United States$0.344B-1.83
Vogenx, Inc. (VOGX)United States$0.355B
Benitec Biopharma Inc. (BNTC)United States$0.337B-10.08
BioAge Labs, Inc. (BIOA)United States$0.333B-11.88
BridgeBio Oncology Therapeutics, Inc. (BBOT)United States$0.320B-3.35
Evommune, Inc. (EVMN)United States$0.320B-5.10
Prelude Therapeutics Inc (PRLD)United States$0.318B-7.01
ABEONA THERAPEUTICS INC. (ABEO)United States$0.312B-5.63
Rezolute, Inc. (RZLT)United States$0.382B-6.45